Biogen defends Alzheimer's drug approval, reports $2 million in early sales 0 22.07.2021 16:11 Business Standard Biogen Inc said the approval of its Alzheimer's disease drug was based on extensive data as it seeks to quell concerns about the drug's effectiveness Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
